Atlas Trials

Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities

Clinical trial NCT05349383 · COMPLETED

Trial details

NCT number
NCT05349383
Sponsor
Central South University
Status
COMPLETED
Study type
OBSERVATIONAL
Sepsis (SMQ)Opportunistic InfectionsAgranulocytosis
Start date
2022-04-22
Primary completion
2022-05-22
Enrollment
24618

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.